Literature DB >> 24611144

Cytomorphological effects of mitomycin C on urothelial cells: eosinophils may be clue to the drug-induced changes.

Gulcin Guler Simsek1, Erdem Vargol1, Hulya Simsek1.   

Abstract

Cytomorphological changes of mitomycin C on urothelial cells may be misinterpreted as a neoplastic process. A 60-year old male patient who was given an eight-week course of intravesical mitomycin C due to non-invasive low grade transitional cell carcinoma. During his follow-up care, the findings of a urine cytology exam were as follows: nuclear enlargement of cells, wrinkled nuclear membranes, little hyperchromasia, pleomorphism, abnormal nuclear morphology and disordered orientation of the urothelium. Furthermore, there were eosinophils nearby the atypical cells. This report aimed at reminding the cytomorphologic changes of mitomycin C may be misinterpreted as carcinoma, so the presence of eosinophils is required to predict the drug-induced changes.

Entities:  

Keywords:  Eosinophil; Mitomycine C; Urothelial Cell

Year:  2014        PMID: 24611144      PMCID: PMC4204180     

Source DB:  PubMed          Journal:  Cell J        ISSN: 2228-5806            Impact factor:   2.479


  6 in total

1.  Prognostic significance of urine cytology on initial follow-up after intravesical mitomycin C for superficial bladder cancer.

Authors:  J D Cant; W M Murphy; M S Soloway
Journal:  Cancer       Date:  1986-06-01       Impact factor: 6.860

2.  The morphologic effects of mitomycin C in mammalian urinary bladder.

Authors:  W M Murphy; M S Soloway; W N Crabtree
Journal:  Cancer       Date:  1981-06-01       Impact factor: 6.860

Review 3.  Current status of urinary cytology in the evaluation of bladder neoplasms.

Authors:  W M Murphy
Journal:  Hum Pathol       Date:  1990-09       Impact factor: 3.466

Review 4.  Diagnosis and management of superficial bladder cancer.

Authors:  C L Amling
Journal:  Curr Probl Cancer       Date:  2001 Jul-Aug       Impact factor: 3.187

Review 5.  An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy.

Authors:  J L Duque; K R Loughlin
Journal:  Urol Clin North Am       Date:  2000-02       Impact factor: 2.241

6.  Value of bladder wash cytology in the follow-up of patients with bladder carcinoma receiving intravesical chemoprophylaxis with mitomycin C.

Authors:  K Hörbarth; U Maier; M Susani
Journal:  Eur Urol       Date:  1991       Impact factor: 20.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.